"Designing Growth Strategies is in our DNA"

Dental Anesthetics Market Size, Share, and Industry Analysis, By Type (Local Anesthesia {Articaine, Bupivacaine, Lidocaine, and Others}, General Anesthesia, and Sedative), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital & Dental Clinics Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast 2025-2032

Region : Global | Report ID: FBI111299 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global dental anesthetics market is set to witness significant growth. Anesthetics are substances that can cause a temporary loss of sensation. They are usually provided to assist with the operation. The increasing incidence of dental issues is expected to propel the dental anesthesia industry. Due to the increasing disposable incomes and growing oral health awareness, the market for dental anesthetics is expected to grow significantly in the upcoming years. It is expected that dental anesthetics will become more popular in emerging countries such as China, India, and Brazil in the coming years due to higher income levels and relatively high DMFT indices (decayed, missing, and filled teeth index).

Dental Anesthetics Market Driver

Increasing Dental Surgery and Implant Cases to Propel Market Growth

The rising prevalence of dental diseases leads to increased demand for dental products for surgeries. In such surgeries, dental anesthesia plays an important role. Such scenarios boosted the utilization of dental anesthetics for dental procedures.

  • For instance, according to an article published by the World Health Organization (WHO) in 2023, oral diseases affect nearly 3.5 billion people. Such scenarios drive the demand for dental anesthetics and thus push the growth of the market.

Download Free sample to learn more about this report.

Dental Anesthetics Market Restraint

Side Effects Associated with Dental Anesthetics to Limit Market Growth

The side effects associated with dental anesthetics may limit its adoption and constrain the market expansion in the forecast period.

  • As per an article published by Faster Capital in 2024, general anesthesia carries inherent risks, including allergic reactions, respiratory issues, and adverse drug interactions. Such factors may hamper the growth of the market.

Dental Anesthetics Market Opportunity

Increased Initiatives for Greater Awareness of Oral Health to Boost Number of Dental Procedures

The increasing number of awareness programs by various organizations to enhance the number of dental procedures conducted is expected to give rise to the greater adoption of dental anesthetic products.

  • As of February 2024, February is considered the National Children's Dental Health Month. On this occasion, the American Association of Nurse Anesthesiology (AANA) reminded parents and caregivers of the importance of not only knowing how to keep their child's teeth healthy but also ensuring that they have access to safe dental anesthesia care. This month-long national health observance brings together thousands of dedicated professionals, healthcare providers, and educators to promote the benefits of good oral health to children, their caregivers, teachers, and many others. Such awareness programs are expected to propel product adoption in the market.

Segmentation

By Type

By Route of Administration

By Distribution Channel

By Geography

  • Local Anesthesia
    • Articaine
    • Bupivacaine
    • Lidocaine
    • Others
  • General Anesthesia
  • Sedative
  • Oral
  • Parenteral
  • Hospital & Dental Clinics Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies
  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Prevalence/Incidence of Key Dental Diseases, By Key Countries/Regions, 2024
  • Number of Dentists, By Key Countries/Regions, 2024
  • Estimated Number of Orthodontists, By Key Countries/Regions, 2024
  • Key Industry Developments (Mergers, Acquisitions, Partnerships)
  • Impact of COVID-19 on the Market

Analysis by Type

By type, the market is divided into local anesthesia {articaine, bupivacaine, lidocaine, and others}, general anesthesia, and sedative.

The local anesthesia segment held a significant portion of the market. The rising demand due to substantial popularity has led to the growth of the segment in the market. Moreover, these are simpler in terms of usage, which enhances its adaptability among patients. Also, a rise in strategic activities by the key market players bolsters the market expansion.

  • In August 2023, 3M completed the sale of certain assets from its dental local anesthetic portfolio to Pierrel S.p.A. for a purchase price of USD 70.0 million, subject to closing and other adjustments. These local anesthetic products, sold primarily in Europe and Asia, include products sold under the Ubistesin, Xylestesin, and Mepivastesin brands, as well as related syringe and needle products. Such strategic activities propel the dental anesthetics market growth.

 Analysis by Route of Administration

By route of administration, the market is divided into oral and parenteral.

The parenteral segment accounts for the largest share of the dental anesthetics market. Intravenous anesthesia is quite common, and even deep levels of sedation are given parenterally. The significant market share is due to its strong adoption by patients and ease of handling by dentists.

  • According to a research study published by Cureus in March 2023, articaine and centbucridine have been demonstrated to be effective dental anesthetics as compared to lignocaine. Articaine and centbucridine can be administered through the parenteral route.

 Analysis by Distribution Channel

By distribution channel, the market is divided into hospital & dental clinics pharmacies, drug stores & retail pharmacies, and online pharmacies.

The hospital & dental clinics pharmacies segment held a prominent portion of the market. The main factors driving the growth of the segment are the increasing number of dental offices globally and the widespread adoption of advanced dentistry by large and small practices. The growth of the market is expected to be further boosted by the rise in the number of dental clinics, particularly in developed nations.

  • For instance, in May 2024, Clove Dental India, one of the largest dental chains, opened its 500th clinic in the country.

Regional Analysis

 

To gain extensive insights into the market, Download for Customization

In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a significant share of the global dental anesthetics market in 2023. The growth of the market in the region is attributed to the region's advanced dental facilities and infrastructure. Moreover, initiatives by key players to expand their supply chain contributed to the dominance of the area in the market.

  • For instance, in November 2021,  Zombies, a U.S.-based company, entered into a partnership with Southern Anesthesia & Surgical, Inc. (SAS) to supply anesthesia and surgical supplies to oral surgeons, dental anesthesiologists, and periodontists. Such an increasing number of initiatives thus led to the adoption of dental anesthetics in the region.

Europe is the second-largest market based on the demand for dental anesthetics. The rising patient population for dental surgeries, growing healthcare infrastructure, and advancements in products led to the growth of the region in the market.

Key Players Covered

The global dental anesthetics market is fragmented, with the presence of a large number of groups and standalone manufacturers. The report includes the profiles of the following key players:

  • Pierrel (Italy)
  • Aspen Group of Companies (South Africa)
  • Centrix (U.S.)
  • Dentsply Sirona (U.S.)
  • Septodont Holding (France)
  • Milestone Scientific, Inc. (U.S.)
  • Primex Pharmaceuticals (Switzerland)

Key Industry Developments

  • In December 2021, Aspen Dental Management, Inc. rebranded its parent company as TAG – The Aspen Group. The new positioning better represents the company's rapid expansion beyond the dental industry into a variety of healthcare businesses, including general dentistry, dental implants, urgent care, and medical aesthetics.
  • In November 2018, Septodont Holding announced the launch of the Dentapen electronic syringe for dental anesthesia.
  • In May 2017, Cetylite Inc. announced the launch of a new mint flavor for their Cetacaine Topical Anesthetic Gel products.


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann